Hagino A
No ORCID on file
· 2 papers in corpus
ObjectiveTo evaluate the efficacy and safety of dienogest (DNG), a progestational 19-norsteroid, in patients with symptomatic adenomyosis.DesignPhase III, randomized, double-blind, multicenter, placebo-controlled study.SettingClinical study…
AIM: We aimed to investigate the safety and efficacy of dienogest (DNG), a progestational 19-norsteroid, administered for 52 weeks in patients with symptomatic adenomyosis. METHODS: A total of 130 patients with adenomyosis received 2 mg of…